Ibuzatrelvir drug study in healthy chinese volunteers completed
NCT ID NCT07235137
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early-stage study looked at how the drug Ibuzatrelvir (PF-07817883) is absorbed and processed in the body of 12 healthy Chinese adults after a single dose. The goal was to measure drug levels in the blood and check for any side effects. Since participants were healthy, this trial does not test treatment for any disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Ibuzatrelvir (PF-07817883)
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Huashan Hospital, Fudan University
Shanghai, Shanghai Municipality, 200040, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Does drug particle size matter? a study puts prifetrastat to the test
- Smoking may weaken dental fillings, new study suggests
- Pfizer tests drug interaction in tiny early study
- Pfizer tests heart drug safety in healthy volunteers
- Can a drug and probiotic combo turn back the clock on aging?
- Pfizer checks if new atirmociclib tablet matches the old one